113 related articles for article (PubMed ID: 9301716)
21. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival.
Yan TD; Chu F; Links M; Kam PC; Glenn D; Morris DL
Eur J Surg Oncol; 2006 Dec; 32(10):1119-24. PubMed ID: 16887321
[TBL] [Abstract][Full Text] [Related]
22. Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis.
McQuellon RP; Loggie BW; Fleming RA; Russell GB; Lehman AB; Rambo TD
Eur J Surg Oncol; 2001 Feb; 27(1):65-73. PubMed ID: 11237495
[TBL] [Abstract][Full Text] [Related]
23. Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer.
Franko J; Gusani NJ; Holtzman MP; Ahrendt SA; Jones HL; Zeh HJ; Bartlett DL
Ann Surg Oncol; 2008 Nov; 15(11):3065-72. PubMed ID: 18712450
[TBL] [Abstract][Full Text] [Related]
24. [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal colorectal carcinomatosis: a newly validated standard whose contribution remains to be assessed].
Pocard M; Boige V
Bull Cancer; 2005 Feb; 92(2):151-4. PubMed ID: 15749644
[TBL] [Abstract][Full Text] [Related]
25. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
Deraco M; Nonaka D; Baratti D; Casali P; Rosai J; Younan R; Salvatore A; Cabras Ad AD; Kusamura S
Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562
[TBL] [Abstract][Full Text] [Related]
26. Signet ring cell adenocarcinoma of the urachus.
Daljeet S; Amreek S; Satish J; Raman A; Hara GS; Lovneesh G; Prabhakar BR; Neeraj A
Int J Urol; 2004 Sep; 11(9):785-8. PubMed ID: 15379946
[TBL] [Abstract][Full Text] [Related]
27. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma.
Chirieac LR; Swisher SG; Correa AM; Ajani JA; Komaki RR; Rashid A; Hamilton SR; Wu TT
Clin Cancer Res; 2005 Mar; 11(6):2229-36. PubMed ID: 15788671
[TBL] [Abstract][Full Text] [Related]
28. Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study.
Rossi CR; Foletto M; Mocellin S; Pilati P; De SM; Deraco M; Cavaliere F; Palatini P; Guasti F; Scalerta R; Lise M
Cancer; 2002 Jan; 94(2):492-9. PubMed ID: 11900234
[TBL] [Abstract][Full Text] [Related]
29. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].
Vaira M; Scuderi S; Costamagna D; Barone R; Aghemo B; Mioli PR; De Simone M
Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661
[TBL] [Abstract][Full Text] [Related]
30. Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer.
Glockzin G; Ghali N; Lang SA; Schlitt HJ; Piso P
J Surg Oncol; 2009 Sep; 100(4):306-10. PubMed ID: 19697436
[TBL] [Abstract][Full Text] [Related]
31. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy.
Verwaal VJ; van Tinteren H; van Ruth S; Zoetmulder FA
Br J Surg; 2004 Jun; 91(6):739-46. PubMed ID: 15164445
[TBL] [Abstract][Full Text] [Related]
32. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ; van Ruth S; de Bree E; van Sloothen GW; van Tinteren H; Boot H; Zoetmulder FA
J Clin Oncol; 2003 Oct; 21(20):3737-43. PubMed ID: 14551293
[TBL] [Abstract][Full Text] [Related]
33. Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin.
Mahteme H; Sugarbaker PH
Br J Surg; 2004 Sep; 91(9):1168-73. PubMed ID: 15449269
[TBL] [Abstract][Full Text] [Related]
34. [Hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis arising from gastric cancer].
Cotte E; Gilly FN; Beaujard AC; Glehen O
Cancer Radiother; 2008 Nov; 12(6-7):653-8. PubMed ID: 18639480
[TBL] [Abstract][Full Text] [Related]
35. Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome.
Verwaal VJ; Boot H; Aleman BM; van Tinteren H; Zoetmulder FA
Ann Surg Oncol; 2004 Apr; 11(4):375-9. PubMed ID: 15070596
[TBL] [Abstract][Full Text] [Related]
36. Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy.
Kecmanovic DM; Pavlov MJ; Ceranic MS; Sepetkovski AV; Kovacevic PA; Stamenkovic AB
Eur J Surg Oncol; 2005 Mar; 31(2):147-52. PubMed ID: 15698730
[TBL] [Abstract][Full Text] [Related]
37. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.
Yan TD; Bijelic L; Sugarbaker PH
Ann Surg Oncol; 2007 Aug; 14(8):2289-99. PubMed ID: 17541772
[TBL] [Abstract][Full Text] [Related]
38. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
Sugarbaker PH
Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
[TBL] [Abstract][Full Text] [Related]
39. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
Bijelic L; Yan TD; Sugarbaker PH
Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
[TBL] [Abstract][Full Text] [Related]
40. Colon and gastric metastases from a primary signet-ring cell carcinoma of the urinary bladder.
Morelli O; Castellani D; Asciutti S; Baldoni M; Familiari L; Nardi E; Morelli A; Clerici C
Dig Liver Dis; 2006 Aug; 38(8):609-11. PubMed ID: 16551516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
